12 Information Technology Stocks Moving In Tuesday’s Intraday Session

Gainers Peraso (NASDAQ:PRSO) shares increased by 37.0% to $1.74 during Tuesday’s regular session. The company’s market cap stands…

Gainers

  • Peraso (NASDAQ:PRSO) shares increased by 37.0% to $1.74 during Tuesday’s regular session. The company’s market cap stands at $4.1 million.
  • Auddia (NASDAQ:AUUD) stock rose 28.55% to $2.44. The market value of their outstanding shares is at $5.8 million.
  • Rigetti Computing (NASDAQ:RGTI) stock moved upwards by 13.88% to $1.23. The company’s market cap stands at $194.5 million.
  • Saverone 2014 (NASDAQ:SVRE) stock rose 13.82% to $0.8. The market value of their outstanding shares is at $12.7 million.
  • Taoping (NASDAQ:TAOP) shares rose 10.47% to $0.95. The market value of their outstanding shares is at $1.8 million.
  • D-Wave Quantum (NYSE:QBTS) shares rose 10.12% to $1.74. The company’s market cap stands at $281.3 million.

Losers

  • OMNIQ (NASDAQ:OMQS) stock fell 24.9% to $0.53 during Tuesday’s regular session. The market value of their outstanding shares is at $5.6 million.
  • NextTrip (NASDAQ:NTRP) stock fell 18.16% to $3.38. The company’s market cap stands at $4.5 million.
  • Minim (NASDAQ:MINM) shares decreased by 17.47% to $4.22. The market value of their outstanding shares is at $12.5 million. The company’s, Q4 earnings came out 2 days ago.
  • Nano Labs (NASDAQ:NA) shares decreased by 16.71% to $0.55. The market value of their outstanding shares is at $56.4 million.
  • VIA optronics (NYSE:VIAO) stock fell 15.59% to $0.26. The market value of their outstanding shares is at $5.8 million.
  • Mobilicom (NASDAQ:MOB) shares fell 15.2% to $1.06. The market value of their outstanding shares is at $5.6 million.
    See Also: www.benzinga.com/money/tech-stocks/

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Vertex Pharmaceutical’s Move Beyond Its $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion in cash. Povetacicept, a potent dual antagonist of BAFF and APRIL, shows promise in IgA nephropathy. Transaction expected to close Q2 2024. VRTX expanding into kidney disease treatment.

ALPN

Read More

Why Coupang Stock Is Up Friday

Coupang will raise its membership fees by 58% beginning on Saturday for new customers, according to a report from the Korean Times. The company's membership service boasts approximately 14 million subscribers and benefits include next-day shipping, free returns, video streaming and Coupang Eats food delivery service. 

CPNG